Healthcare
Sigyn Therapeutics
Recorded January 09, 2025
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
A clinical-stage precision medicine company enhancing patient outcomes through improved decision-making and personalized cancer care.
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively, safely, and compassionately.
Developing drugs aimed at the central nervous system to treat neurological disorders including Alzheimer’s, chronic pain, and obesity
Direct Biologics is a clinical-stage biotech innovator that is harnessing signaling molecules to reduce overactive inflammatory response
Rock Fiber is revolutionizing the $100B structural materials market with its innovative and sustainable, high-performance fiber products.
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
A biotech company developing a platform of novel antibodies and ADCs to treat life-threatening cancers including leukemia and lymphoma
Ingenious, patented micro-hydroelectric energy recovery system produces renewable energy from the water that flows through municipal pipes
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ to make cancer less lethal.
The company’s AI-powered drug development program has the potential to treat multiple CNS diseases and impact millions of lives.